Literature DB >> 2997218

Photoaffinity labeling of A1-adenosine receptors.

K N Klotz, G Cristalli, M Grifantini, S Vittori, M J Lohse.   

Abstract

The ligand-binding subunit of the A1-adenosine receptor has been identified by photoaffinity labeling. A photolabile derivative of R-N6-phenylisopropyladenosine, R-2-azido-N6-p-hydroxyphenylisopropyladenosine (R-AHPIA), has been synthesized as a covalent specific ligand for A1-adenosine receptors. In adenylate cyclase studies with membranes of rat fat cells and human platelets, R-AHPIA has adenosine receptor agonist activity with a more than 60-fold selectivity for the A1-subtype. It competes for [3H]N6-phenylisopropyladenosine binding to A1-receptors of rat brain membranes with a Ki value of 1.6 nM. After UV irradiation, R-AHPIA binds irreversibly to the receptor, as indicated by a loss of [3H]N6-phenylisopropyladenosine binding after extensive washing; the Ki value for this photoinactivation is 1.3 nM. The p-hydroxyphenyl substituent of R-AHPIA can be directly radioiodinated to give a photoaffinity label of high specific radioactivity (125I-AHPIA). This compound has a KD value of about 1.5 nM as assessed from saturation and kinetic experiments. Adenosine analogues compete for 125I-AHPIA binding to rat brain membranes with an order of potency characteristic for A1-adenosine receptors. Dissociation curves following UV irradiation at equilibrium demonstrate 30-40% irreversible specific binding. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicates that the probe is photoincorporated into a single peptide of Mr = 35,000. Labeling of this peptide can be blocked specifically and stereoselectively by adenosine receptor agonists and antagonists in a manner which is typical for the A1-subtype. The results indicate that 125I-AHPIA identifies the ligand-binding subunit of the A1-adenosine receptor, which is a peptide with Mr = 35,000.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

2.  Exploring the Role of N6-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇.

Authors:  Riccardo Petrelli; Mirko Scortichini; Sonja Kachler; Serena Boccella; Carmen Cerchia; Ilaria Torquati; Fabio Del Bello; Daniela Salvemini; Ettore Novellino; Livio Luongo; Sabatino Maione; Kenneth A Jacobson; Antonio Lavecchia; Karl-Norbert Klotz; Loredana Cappellacci
Journal:  J Med Chem       Date:  2017-05-05       Impact factor: 7.446

3.  Demonstration of distinct agonist and antagonist conformations of the A1 adenosine receptor.

Authors:  W W Barrington; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

4.  28 kDa adenosine-binding proteins of brain and other tissues.

Authors:  K Ravid; R A Rosenthal; S R Doctrow; J M Lowenstein
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.

Authors:  Kyle Jensen; L'Aurelle A Johnson; Pamala A Jacobson; Sonja Kachler; Mark N Kirstein; Jatinder Lamba; Karl-Norbert Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

6.  A1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C.

Authors:  S Freund; M Ungerer; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

7.  Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.

Authors:  K N Klotz; H Vogt; H Tawfik-Schlieper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

8.  2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.

Authors:  K N Klotz; M J Lohse; U Schwabe; G Cristalli; S Vittori; M Grifantini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

9.  A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1987-08       Impact factor: 4.436

10.  Persistent cAMP-signals triggered by internalized G-protein-coupled receptors.

Authors:  Davide Calebiro; Viacheslav O Nikolaev; Maria Cristina Gagliani; Tiziana de Filippis; Christian Dees; Carlo Tacchetti; Luca Persani; Martin J Lohse
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.